GB2336109A - Ophthalmic Irrigating Solution - Google Patents
Ophthalmic Irrigating Solution Download PDFInfo
- Publication number
- GB2336109A GB2336109A GB9807491A GB9807491A GB2336109A GB 2336109 A GB2336109 A GB 2336109A GB 9807491 A GB9807491 A GB 9807491A GB 9807491 A GB9807491 A GB 9807491A GB 2336109 A GB2336109 A GB 2336109A
- Authority
- GB
- United Kingdom
- Prior art keywords
- irrigating solution
- solution according
- ocular irrigating
- solution
- ocular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000013010 irrigating solution Substances 0.000 title claims abstract description 30
- 239000000243 solution Substances 0.000 claims abstract description 42
- 239000000872 buffer Substances 0.000 claims abstract description 19
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 8
- 239000008103 glucose Substances 0.000 claims abstract description 8
- 238000001356 surgical procedure Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 230000003139 buffering effect Effects 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 abstract description 6
- 239000007995 HEPES buffer Substances 0.000 abstract description 6
- 230000008753 endothelial function Effects 0.000 abstract description 5
- 239000000654 additive Substances 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 description 16
- 210000004087 cornea Anatomy 0.000 description 14
- 239000003855 balanced salt solution Substances 0.000 description 9
- 108010014606 glutathione-bicarbonate-Ringer solution Proteins 0.000 description 9
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 8
- 229940082649 blood substitutes and perfusion irrigating solutions Drugs 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000002262 irrigation Effects 0.000 description 6
- 238000003973 irrigation Methods 0.000 description 6
- 230000003511 endothelial effect Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229940113601 irrigation solution Drugs 0.000 description 5
- 108010024636 Glutathione Proteins 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 210000003038 endothelium Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- NHWZQIYTQZEOSJ-UHFFFAOYSA-N carbonic acid;phosphoric acid Chemical compound OC(O)=O.OP(O)(O)=O NHWZQIYTQZEOSJ-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Devices For Medical Bathing And Washing (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9807491A GB2336109A (en) | 1998-04-07 | 1998-04-07 | Ophthalmic Irrigating Solution |
| DE69914066T DE69914066T2 (de) | 1998-04-07 | 1999-04-07 | Augenspüllösung |
| JP2000541976A JP2002510613A (ja) | 1998-04-07 | 1999-04-07 | 眼灌注溶液 |
| PCT/GB1999/001066 WO1999051204A1 (en) | 1998-04-07 | 1999-04-07 | Ocular irrigating solution |
| AT99915876T ATE257371T1 (de) | 1998-04-07 | 1999-04-07 | Augenspüllösung |
| ES99915876T ES2216502T3 (es) | 1998-04-07 | 1999-04-07 | Solucion de irrigacion ocular. |
| EP99915876A EP1067907B1 (en) | 1998-04-07 | 1999-04-07 | Ocular irrigating solution |
| DK99915876T DK1067907T3 (da) | 1998-04-07 | 1999-04-07 | Okulær udskylningsoplösning |
| AU34303/99A AU3430399A (en) | 1998-04-07 | 1999-04-07 | Ocular irrigating solution |
| PT99915876T PT1067907E (pt) | 1998-04-07 | 1999-04-07 | Solucao para irrigacao ocular |
| US11/376,431 US20060177524A1 (en) | 1998-04-07 | 2006-03-14 | Ocular irrigating solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9807491A GB2336109A (en) | 1998-04-07 | 1998-04-07 | Ophthalmic Irrigating Solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9807491D0 GB9807491D0 (en) | 1998-06-10 |
| GB2336109A true GB2336109A (en) | 1999-10-13 |
Family
ID=10830016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9807491A Withdrawn GB2336109A (en) | 1998-04-07 | 1998-04-07 | Ophthalmic Irrigating Solution |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060177524A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1067907B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002510613A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE257371T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU3430399A (cg-RX-API-DMAC7.html) |
| DE (1) | DE69914066T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1067907T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2216502T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2336109A (cg-RX-API-DMAC7.html) |
| PT (1) | PT1067907E (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999051204A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1734965A4 (en) * | 2004-03-31 | 2008-06-11 | Advanced Vision Res Inc | COMPOSITIONS AND METHODS FOR PROVIDING ELEPHANT HYGIENE |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007055046A1 (de) * | 2007-11-19 | 2009-05-28 | Fluoron Gmbh | Infusionslösung |
| EP2555780B1 (en) * | 2010-04-09 | 2016-02-24 | National Health Research Institutes | Gamma-polyglutamic acid-based ocular irrigating solutions |
| KR102411018B1 (ko) | 2015-08-18 | 2022-06-20 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 임상 제제 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987000753A1 (en) * | 1985-08-01 | 1987-02-12 | Lindstrom Richard L | Irrigation solution |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2064320B (en) * | 1979-10-13 | 1983-10-12 | Welsh Nat School Med | Intra-ocular irrigation fluid |
| US4443432A (en) * | 1981-10-05 | 1984-04-17 | Alcon Laboratories, Inc. | Ophthmalic irrigating solution |
| FR2602677B1 (fr) * | 1986-08-14 | 1992-03-06 | Blomet Marie Claude | Solution physiologique pour le lavage des parties du corps humain ou animal ayant ete mises en contact avec un acide ou une base, et concentre pour sa preparation |
| FR2656527B1 (fr) * | 1989-12-29 | 1992-04-10 | Anben | Solution d'irrigation oculaire utilisee en therapeutique pour la protection endotheliale et la conservation de la cornee. |
| US5523316A (en) * | 1994-06-23 | 1996-06-04 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing agent for controlling IOP |
| EP0778021A4 (en) * | 1994-09-14 | 1998-06-03 | Taisho Pharmaceutical Co Ltd | DROPS TO CARE FOR THE CORNEA |
| DE19626479A1 (de) * | 1996-07-02 | 1998-01-08 | Schrage Norbert Dr Med | Medikamentengrundlage für die lokale Anwendung am Auge |
-
1998
- 1998-04-07 GB GB9807491A patent/GB2336109A/en not_active Withdrawn
-
1999
- 1999-04-07 AU AU34303/99A patent/AU3430399A/en not_active Abandoned
- 1999-04-07 DE DE69914066T patent/DE69914066T2/de not_active Expired - Fee Related
- 1999-04-07 EP EP99915876A patent/EP1067907B1/en not_active Expired - Lifetime
- 1999-04-07 WO PCT/GB1999/001066 patent/WO1999051204A1/en not_active Ceased
- 1999-04-07 PT PT99915876T patent/PT1067907E/pt unknown
- 1999-04-07 DK DK99915876T patent/DK1067907T3/da active
- 1999-04-07 AT AT99915876T patent/ATE257371T1/de not_active IP Right Cessation
- 1999-04-07 ES ES99915876T patent/ES2216502T3/es not_active Expired - Lifetime
- 1999-04-07 JP JP2000541976A patent/JP2002510613A/ja active Pending
-
2006
- 2006-03-14 US US11/376,431 patent/US20060177524A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987000753A1 (en) * | 1985-08-01 | 1987-02-12 | Lindstrom Richard L | Irrigation solution |
Non-Patent Citations (2)
| Title |
|---|
| Chemical Abstract No, 114:202994 & Atarashii Ganka 1991, (1), 129-33. * |
| Chemical Abstract No. 115:154362 & Atarashii Ganka 1991, (4), 623-7. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1734965A4 (en) * | 2004-03-31 | 2008-06-11 | Advanced Vision Res Inc | COMPOSITIONS AND METHODS FOR PROVIDING ELEPHANT HYGIENE |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2216502T3 (es) | 2004-10-16 |
| ATE257371T1 (de) | 2004-01-15 |
| PT1067907E (pt) | 2004-05-31 |
| DE69914066D1 (de) | 2004-02-12 |
| AU3430399A (en) | 1999-10-25 |
| EP1067907A1 (en) | 2001-01-17 |
| WO1999051204A1 (en) | 1999-10-14 |
| EP1067907B1 (en) | 2004-01-07 |
| US20060177524A1 (en) | 2006-08-10 |
| GB9807491D0 (en) | 1998-06-10 |
| DK1067907T3 (da) | 2004-05-17 |
| JP2002510613A (ja) | 2002-04-09 |
| DE69914066T2 (de) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0076658B1 (en) | Ophthalmic irrigating solution | |
| US4550022A (en) | Tissue irrigating solution | |
| EP0517972A1 (en) | Define serum-free medical solution and use thereof | |
| US4238482A (en) | Intraocular infusion irrigation solution and method | |
| US6495598B1 (en) | Perfusate preparation for ophthalmic operation | |
| US4837021A (en) | Two part tissue irrigating solution | |
| McDermott et al. | Ophthalmic irrigants: a current review and update | |
| US5221537A (en) | Tissue irrigating solutions | |
| Yau et al. | A medium-term corneal preserving medium (K-Sol) | |
| EP1067907B1 (en) | Ocular irrigating solution | |
| WO1995016435A2 (en) | Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent | |
| JPH0748262A (ja) | 外眼部投与用組成物 | |
| Lindstrom et al. | Corneal preservation at 4 degrees C with chondroitin sulfate containing medium | |
| JP3228699B2 (ja) | 眼手術用灌流液製剤 | |
| WO1991017469A1 (en) | Kit for contact lenses | |
| KR100550023B1 (ko) | 눈 수술용 관류액 제제 | |
| RU2115413C1 (ru) | Ирригационный раствор "интрасол" | |
| US12527752B2 (en) | Composition based on gellan gum and phenylephrine, production method and use as an ophthalmic product | |
| Burke et al. | Safety evaluation of BSS plus in pediatric intraocular surgery | |
| Guerin et al. | Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System | |
| Staatz et al. | Effects of phenylephrine on bovine corneal endothelium in culture | |
| TW519492B (en) | Irrigation composition comprised D-3- hydroxybutyricacid and water soluble salt for an ophthalmic operation | |
| WO2001074393A1 (fr) | Agents de protection des tissus vitaux | |
| JPWO2001074393A1 (ja) | 生体組織保護剤 | |
| KR20010106511A (ko) | 안구 수술용 관류액 제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |